Emergent BioSolutions (EBS) Non Operating Income (2011 - 2026)
Emergent BioSolutions (EBS) posted Non Operating Income of $900,000 for Q3 2026, compared with -$18.9 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) Non Operating Income (2011 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Non Operating Income at Emergent BioSolutions was -$60.2 million; for FY2025, it was -$17.3 million.
- In prior years, Emergent BioSolutions' Non Operating Income was -$34.2 million in FY2024, -$4.8 million in FY2023, -$49 million in FY2022 and -$38.2 million in FY2021.
- Quarterly Non Operating Income has run from a low of -$66.3 million in Q2 2024 to a high of $77.9 million in Q3 2024 over five years.
- According to Business Quant data, Non Operating Income for the three prior quarters was -$41.2 million (Q2 2026), $2.9 million (Q1 2026) and -$22.8 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | - |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn | 900,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 900,000.00 |
| Jun 30, 2026 | -41.20 Mn |
| Mar 31, 2026 | 2.90 Mn |
| Dec 31, 2025 | -22.80 Mn |
| Sep 30, 2025 | -18.90 Mn |
| Jun 30, 2025 | -18.40 Mn |
| Mar 31, 2025 | 42.80 Mn |
| Dec 31, 2024 | -18.10 Mn |
| Sep 30, 2024 | 77.90 Mn |
| Jun 30, 2024 | -66.30 Mn |
| Mar 31, 2024 | -27.70 Mn |
| Dec 31, 2023 | -10.70 Mn |
| Sep 30, 2023 | -23.80 Mn |
| Jun 30, 2023 | 42.70 Mn |
| Mar 31, 2023 | -13.00 Mn |
| Dec 31, 2022 | -6.10 Mn |
| Sep 30, 2022 | -21.90 Mn |
| Jun 30, 2022 | -10.80 Mn |
| Mar 31, 2022 | -10.20 Mn |
| Dec 31, 2021 | -9.90 Mn |
API Access
Emergent BioSolutions Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();